Clinical trial

PDE5 Inhibition for Obesity-Related Cardiometabolic Dysfunction

NCT02819440

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-07-01

PhasePHASE2

Study timeline

Study start (unknown)2016-07-01Date precision: month

Registry last updated2022-05-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthyunresolved

Obeseunresolved

Interventions

TadalafilDRUG · verified · RxNorm: tadalafil

PlaceboDRUG

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02819440 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.